<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">18206</article-id><article-id pub-id-type="doi">10.7554/eLife.18206</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>SF-1 expression in the hypothalamus is required for beneficial metabolic effects of exercise</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-58635"><name><surname>Fujikawa</surname><given-names>Teppei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-58832"><name><surname>Castorena</surname><given-names>Carlos M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58833"><name><surname>Pearson</surname><given-names>Mackenzie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33696"><name><surname>Kusminski</surname><given-names>Christine M</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58834"><name><surname>Ahmed</surname><given-names>Newaz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58835"><name><surname>Battiprolu</surname><given-names>Pavan K</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58836"><name><surname>Kim</surname><given-names>Ki Woo</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28159"><name><surname>Lee</surname><given-names>Syann</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45001"><name><surname>Hill</surname><given-names>Joseph A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28162"><name><surname>Scherer</surname><given-names>Philipp E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-16139"><name><surname>Holland</surname><given-names>William L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-28164"><name><surname>Elmquist</surname><given-names>Joel K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6929-6370</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Internal Medicine, Division of Hypothalamic Research</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Touchstone Diabetes Center, Department of Internal Medicine</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Internal Medicine, Division of Cardiology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Pharmacology</institution>, <institution>Wonju College of Medicine, Yonsei University</institution>, <addr-line><named-content content-type="city">Wonju</named-content></addr-line>, <country>South Korea</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Global Medical Science</institution>, <institution>Wonju College of Medicine, Yonsei University</institution>, <addr-line><named-content content-type="city">Wonju</named-content></addr-line>, <country>South Korea</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Institute of Lifestyle Medicine and Nuclear Receptor Research Consortium</institution>, <institution>Wonju College of Medicine, Yonsei University</institution>, <addr-line><named-content content-type="city">Wonju</named-content></addr-line>, <country>South Korea</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Department of Molecular Biology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">Department of Cell Biology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><label>9</label><institution content-type="dept">Department of Pharmacology</institution>, <institution>University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Palmiter</surname><given-names>Richard D</given-names></name><role>Reviewing editor</role><aff id="aff10"><institution>Howard Hughes Medical Institute, University of Washington</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>Joel.Elmquist@utsouthwestern.edu</email></corresp><fn fn-type="con" id="equal-contrib"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>e18206</elocation-id><history><date date-type="received"><day>25</day><month>05</month><year>2016</year></date><date date-type="accepted"><day>14</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Fujikawa et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Fujikawa et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-18206-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.18206.001</object-id><p>Exercise has numerous beneficial metabolic effects. The central nervous system (CNS) is critical for regulating energy balance and coordinating whole body metabolism. However, a role for the CNS in the regulation of metabolism in the context of the exercise remains less clear. Here, using genetically engineered mice we assessed the requirement of steroidogenic factor-1 (SF-1) expression in neurons of the ventromedial hypothalamic nucleus (VMH) in mediating the beneficial effects of exercise on metabolism. We found that VMH-specific deletion of SF-1 blunts (a) the reductions in fat mass, (b) improvements in glycemia, and (c) increases in energy expenditure that are associated with exercise training. Unexpectedly, we found that SF-1 deletion in the VMH attenuates metabolic responses of skeletal muscle to exercise, including induction of PGC-1α expression. Collectively, this evidence suggests that SF-1 expression in VMH neurons is required for the beneficial effects of exercise on metabolism.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.001">http://dx.doi.org/10.7554/eLife.18206.001</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>hypothalamus</kwd><kwd>metabolism</kwd><kwd>exercise</kwd><kwd>VMH</kwd><kwd>SF-1</kwd><kwd>Nr5a1</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R00DK094973</award-id><principal-award-recipient><name><surname>Fujikawa</surname><given-names>Teppei</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>14SDG17950008</award-id><principal-award-recipient><name><surname>Castorena</surname><given-names>Carlos M</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2013R1A1A1007693</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Ki Woo</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004917</institution-id><institution>Cancer Prevention and Research Institute of Texas</institution></institution-wrap></funding-source><award-id>RP110486P3</award-id><principal-award-recipient><name><surname>Hill</surname><given-names>Joseph A</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001674</institution-id><institution>Fondation Leducq</institution></institution-wrap></funding-source><award-id>11CVD04</award-id><principal-award-recipient><name><surname>Hill</surname><given-names>Joseph A</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL-120732</award-id><principal-award-recipient><name><surname>Hill</surname><given-names>Joseph A</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01 DK100659</award-id><principal-award-recipient><name><surname>Hill</surname><given-names>Joseph A</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>P01 DK088761</award-id><principal-award-recipient><name><surname>Hill</surname><given-names>Joseph A</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>14SFRN20740000</award-id><principal-award-recipient><name><surname>Scherer</surname><given-names>Philipp E</given-names></name><name><surname>Elmquist</surname><given-names>Joel K</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>HL-100401</award-id><principal-award-recipient><name><surname>Holland</surname><given-names>William L</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>F32 DK104659</award-id><principal-award-recipient><name><surname>Elmquist</surname><given-names>Joel K</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>DK100659</award-id><principal-award-recipient><name><surname>Elmquist</surname><given-names>Joel K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The transcription factor steroidogenic factor-1 in the hypothalamus is required for adaptive metabolic responses to exercise training.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Obesity and its associated metabolic disorders, such as type two diabetes, are major public health and economic burdens around the world (<xref ref-type="bibr" rid="bib13">Dobbs et al., 2014</xref>). Exercise can be an effective lifestyle intervention to combat obesity and metabolic diseases (<xref ref-type="bibr" rid="bib20">Handschin and Spiegelman, 2008</xref>). Moreover, the combined efficacy of exercise and dietary regimens on type two diabetes can surpass that of pharmacological interventions alone (<xref ref-type="bibr" rid="bib31">Knowler et al., 2002</xref>). Previous efforts aimed at identifying molecular mechanisms underlying the adaptive responses to exercise have mainly focused on the effects of exercise training in an organ or cell autonomous manner (<xref ref-type="bibr" rid="bib16">Egan and Zierath, 2013</xref>; <xref ref-type="bibr" rid="bib22">Hawley et al., 2014</xref>). Despite the increased understanding of the importance of the CNS underlying metabolic homeostasis (<xref ref-type="bibr" rid="bib19">Gautron et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Morton et al., 2014</xref>), the specific neuronal groups and pathways that contribute to the metabolic responses during and following exercise remain largely unclear.</p><p>The hypothalamus plays a key role in the central control of energy balance and glucose homeostasis (<xref ref-type="bibr" rid="bib19">Gautron et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Morton et al., 2014</xref>). In particular, the ventral medial nucleus of the hypothalamus (VMH) and the orphan nuclear receptor, steroidogenic factor-1 (SF-1; official gene name <italic>Nr5a1</italic>) are critical for the regulation of metabolism (<xref ref-type="bibr" rid="bib7">Cheung et al., 2013</xref>; <xref ref-type="bibr" rid="bib27">Kim et al., 2011a</xref>; <xref ref-type="bibr" rid="bib42">Parker et al., 2002</xref>). Within the brain, SF-1 is expressed within the VMH and several studies have demonstrated that SF-1-expressing neurons (SF-1 neurons), and SF-1 itself, are required for adaptive responses to metabolic challenges that occur with high-fat diet (HFD) feeding (<xref ref-type="bibr" rid="bib9">Choi et al., 2013</xref>). VMH-specific deletions of SF-1 and other genes such as <italic>Sirt1</italic>, <italic>Slc17a6</italic>, and <italic>Esr1</italic> blunt the adaptive thermogenic response to HFD (<xref ref-type="bibr" rid="bib28">Kim et al., 2011b</xref>; <xref ref-type="bibr" rid="bib45">Ramadori et al., 2011</xref>; <xref ref-type="bibr" rid="bib58">Tong et al., 2007</xref>; <xref ref-type="bibr" rid="bib64">Xu et al., 2010</xref>). Interestingly, these deletions had modest effects in chow-fed mice (<xref ref-type="bibr" rid="bib9">Choi et al., 2013</xref>). These data suggest that SF-1 in the VMH may regulate a transcriptional program required for responding to metabolic challenges such as HFD-feeding. Exercise is a robust metabolic challenge. We therefore postulated that SF-1 expression in the VMH may also be essential for mediating the beneficial effects of exercise on metabolism. To test our hypothesis, we produced mice with VMH-specific deletions of SF-1 and assessed several metabolic parameters following exercise training.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Deletion of SF-1 in the VMH impairs endurance exercise capacity</title><p>We first examined whether exercise affects the expression of SF-1 and putative SF-1 target genes, including brain-derived neurotrophic factor (<italic>Bdnf</italic>), cannabinoid receptor 1 (<italic>Cnr1</italic>), and corticotrophin releasing hormone receptor 2 (<italic>Crhr2</italic>) (<xref ref-type="bibr" rid="bib26">Kim et al., 2008</xref>, <xref ref-type="bibr" rid="bib29">2009</xref>, <xref ref-type="bibr" rid="bib28">2011b</xref>; <xref ref-type="bibr" rid="bib59">Tran et al., 2006</xref>). We found that exercise training significantly increased mRNA levels of SF-1, <italic>Bdnf</italic>, <italic>Cnr1</italic>, and <italic>Crhr2</italic> in the mediobasal hypothalamus (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). This suggests that exercise may modulate the levels of SF-1 itself and thus putative SF-1 target genes.</p><p>The SF-1 expression is restricted and includes the VMH, the anterior pituitary gland, the adrenal gland and the gonads (<xref ref-type="bibr" rid="bib42">Parker et al., 2002</xref>). To directly test whether SF-1 in the hypothalamus is required for the regulation of metabolism during exercise, we selectively deleted the SF-1 expression in the VMH (VMH<sup>∆SF-1</sup> mice) by crossing mice expressing the floxed SF-1 allele with CamKII-Cre mice, as previously described (<xref ref-type="bibr" rid="bib28">Kim et al., 2011b</xref>). Of note, SF-1 expression in the pituitary gland, adrenal gland, and the gonads is intact in VMH<sup>∆SF-1</sup> mice (<xref ref-type="bibr" rid="bib28">Kim et al., 2011b</xref>).</p><p>Deletion of SF-1 in the VMH did not affect body weight, glucose levels, oxygen consumption, or food intake in sedentary chow-fed mice (<xref ref-type="bibr" rid="bib28">Kim et al., 2011b</xref>) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). We then assessed the endurance capacity of VMH<sup>∆SF-1</sup> mice using a motorized treadmill (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). We found that VMH<sup>∆SF-1</sup> mice exhibited significantly lower endurance-exercise capacity compared to control mice (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We used these results to design the exercise-training paradigms in the following experiments (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>).<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.18206.002</object-id><label>Figure 1.</label><caption><title>Deletion of SF-1 in the VMH attenuates endurance exercise capacity.</title><p>(<bold>A</bold>) Distance run during an endurance capacity test in mice lacking SF-1 only in the VMH (VMH<sup>∆SF-1</sup>) and control mice (age = 12–16 weeks). (<bold>B</bold>) Heart rate, (<bold>C</bold>) left ventricle end-diastolic diameters (LVEDD), and (<bold>D</bold>) left ventricle end-systolic diameters (LVESD) was determined by echocardiography (age = 20–28 weeks) in sedentary VMH<sup>∆SF-1</sup> and control mice. Oxygen-consumption rates (OCRs) in mitochondria isolated from TA muscle, in response to sequential (<bold>E</bold>) succinate- and (<bold>F</bold>) ADP-stimulation, were used for mitochondrial respiratory function (n = 5; age = 12–16 weeks). (<bold>G</bold>) Free fatty acid levels in the plasma in sedentary mice, and (<bold>H</bold>) after a single exercise (n = 8–11). Plasma was collected immediately after the exercise session (15 m/min for 60 min). Mice were fed with chow diet. Values are mean ± S.E.M. ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.002">http://dx.doi.org/10.7554/eLife.18206.002</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig1-v1"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Exercise training increases mRNA levels of SF-1 and SF-1 target genes in the mediobasal hypothalamus.</title><p>Two weeks of exercise training (15 m/min for 60 min per day, five days per week) increases mRNA levels of (<bold>A</bold>) <italic>Nr5a1</italic> (SF-1), (<bold>B</bold>) <italic>Bdnf</italic>, (<bold>C</bold>) <italic>Cnr1</italic>, and (<bold>D</bold>) <italic>Crhr2</italic> in the mediobasal hypothalamus of C57BL/6J mice. The mediobasal hypothalamus was collected 2 hr after the last bout of exercise training. Values are mean ± S.E.M. **p&lt;0.01, ***p&lt;0.001</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.003">http://dx.doi.org/10.7554/eLife.18206.003</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig1-figsupp1-v1"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Deletion of SF-1 in the VMH does not affect basal metabolic rate in chow-fed sedentary mice.</title><p>(<bold>A</bold>) Body weight, (<bold>B</bold>) lean mass, (<bold>C</bold>) fat mass, (<bold>D</bold>) blood glucose, (<bold>E</bold>) oxygen consumption, (<bold>F</bold>) CO2 production, and (<bold>G</bold>) food intake were measured. All mice were fed with a chow diet under sedentary conditions. Values are mean ± S.E.M</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.004">http://dx.doi.org/10.7554/eLife.18206.004</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig1-figsupp2-v1"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.005</object-id><label>Figure 1—figure supplement 3.</label><caption><title>Exercise training regimen.</title><p>Detailed outline of the exercise regimens used for (<bold>A</bold>) endurance capacity test, (<bold>B</bold>) single bout of exercise, and (<bold>C</bold>) prolonged exercise training.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.005">http://dx.doi.org/10.7554/eLife.18206.005</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig1-figsupp3-v1"/></fig></fig-group></p><p>We explored potential mechanisms underlying the lowered endurance capacity of VMH<sup>∆SF-1</sup> mice. Echocardiography revealed normal cardiac function, and function of isolated mitochondria from skeletal muscle were not impaired in VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig1">Figure 1B–E</xref>). Previous studies have shown that blockade of VMH neuronal activity reduces circulating free fatty acids (FFAs) during and after exercise (<xref ref-type="bibr" rid="bib38">Miyaki et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Scheurink et al., 1988</xref>), and FFA utilization during exercise (<xref ref-type="bibr" rid="bib38">Miyaki et al., 2011</xref>). FFAs are a critical energy resource for endurance exercise (<xref ref-type="bibr" rid="bib24">Horowitz, 2003</xref>), and disruption of FFA mobilization can impede endurance capacity (<xref ref-type="bibr" rid="bib14">Dubé et al., 2015</xref>). FFAs between control and VMH<sup>∆SF-1</sup> mice were comparable in sedentary mice (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). In contrast, several species of circulating FFAs in VMH<sup>∆SF-1</sup> mice were significantly lower (<xref ref-type="fig" rid="fig1">Figure 1H</xref>) following a single exercise bout (15 m/min for 60 min, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). These data suggest that VMH<sup>∆SF-1</sup> mice have an impaired mobilization of FFAs in response to exercise, which may contribute to their reduced endurance capacity.</p></sec><sec id="s2-2"><title>Deletion of SF-1 in the VMH blunts fat-reducing effects of exercise training</title><p>Exercise training improves body composition by reducing fat mass and increasing (or maintaining) lean mass (<xref ref-type="bibr" rid="bib16">Egan and Zierath, 2013</xref>). We tested whether deletion of SF-1 in the VMH affected exercise-induced metabolic improvements. We first used a HFD-induced obesity model. Compared to sedentary mice, we found that exercise training significantly attenuated HFD-induced obesity in both VMH<sup>∆SF-1</sup> and control mice as compared to sedentary mice (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). However, exercised-VMH<sup>∆SF-1</sup> mice displayed impaired improvements in body weight and body composition and displayed greater adiposity versus exercised-control mice (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>). Following training, control mice also had significant reductions in circulating glucose levels. This effect was attenuated in exercised-VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig2">Figure 2F</xref>).<fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.18206.006</object-id><label>Figure 2.</label><caption><title>Deletion of SF-1 in the VMH attenuates exercise-mediated reductions in fat mass.</title><p>(<bold>A</bold>) Weekly body weight, (<bold>B</bold>) the change (Δ) in body weight between baseline (week 0) to post-exercise training (week 5), (<bold>C</bold>) body composition, (<bold>D</bold>) lean mass, (<bold>E</bold>) fat mass, and (<bold>F</bold>) glucose in the blood during the post-exercise training period for control and VMH<sup>∆SF-1</sup> mice that either remained sedentary (Control-Sed and VMH<sup>∆SF-1</sup>-Sed) or were exercised (Control-Train and VMH<sup>∆SF-1</sup>-Train). Exercised and sedentary mice were housed together and all mice were fed with high-fat diet beginning at week −1 (age = 8–12 weeks). Exercise training was conducted on a treadmill at a speed of 15 m/min (incline 10°) for 60 min per day, five days per week for weeks 0–5 (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). For body composition (<bold>C</bold>), * indicates statistical analysis for % lean mass and † indicates statistical analysis for % fat mass. Values are mean ± S.E.M. ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05; †††p&lt;0.001, ††p&lt;0.01, and †p&lt;0.05.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.006">http://dx.doi.org/10.7554/eLife.18206.006</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig2-v1"/></fig></p><p>Exercise training can increase energy expenditure in adult rodents (<xref ref-type="bibr" rid="bib23">He et al., 2012</xref>). We hypothesized that a blunted increase in metabolic rate could account for the accumulation of fat mass in VMH<sup>∆SF-1</sup> mice. To directly test this, we assessed the metabolic rate in chow-fed mice after prolonged exercise training (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). Exercise training increased resting oxygen consumption in controls following the last bout of exercise. This response was blunted in VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). In line with the lack of an increase in oxygen consumption, training-induced increases in heat production were blunted in VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Changes in body weight (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>), water intake and ambulatory movement (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) were comparable between exercised-VMH<sup>∆SF-1</sup> and exercised control mice. We found that exercise training altered respiratory exchange ratio and food intake in control mice, but not in VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>). Collectively, these data suggest that the loss of SF-1 in the VMH blunts exercise-induced increases in oxygen consumption, and consequently attenuates exercise-induced reductions in fat mass.<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.18206.007</object-id><label>Figure 3.</label><caption><title>Deletion of SF-1 in the VMH blunts increases in basal metabolic rate and decreases lean mass in response to exercise training.</title><p>The metabolic analysis was performed following eight weeks of exercise training. (<bold>A–B</bold>) Oxygen consumption. (<bold>C</bold>) The area under the curve for oxygen consumption over 24 hr (54 to 78 hr after the last bout of exercise). (<bold>D</bold>) Weekly body weight, (<bold>E</bold>) body weight differences [from baseline (week 0) vs. week 8], (<bold>F</bold>) body composition, (<bold>G</bold>) lean mass, and (<bold>H</bold>) fat mass after eight weeks of exercise training for control and VMH<sup>∆SF-1</sup> mice that either remained sedentary (Control-Sed and VMH<sup>∆SF-1</sup>-Sed) or were exercised (Control-Train and VMH<sup>∆SF-1</sup>-Train). The same exercise regime as described in <xref ref-type="fig" rid="fig2">Figure 2</xref> (See also <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>) was used. All mice were fed with chow diet. For body composition (<bold>F</bold>), † indicates statistical analysis for % fat mass. Values are mean ± S.E.M. *p&lt;0.05 and †p&lt;0.05.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.007">http://dx.doi.org/10.7554/eLife.18206.007</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig3-v1"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.008</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Deletion of SF-1 in the VMH does not affect food intake, water intake and ambulatory movement after exercise training.</title><p>(<bold>A</bold>) Heat production, (<bold>B</bold>) CO2 production, (<bold>C</bold>) food intake, (<bold>D</bold>) respiratory exchange ratio, (<bold>E</bold>) water intake and (<bold>F</bold>) ambulatory movement were measured after eight weeks of exercise training in the VMH<sup>∆SF-1</sup> mice (54 to 78 hr after the last bout of exercise, as described in <xref ref-type="fig" rid="fig3">Figure 3</xref>). All mice were fed with chow diet. Values are mean ± S.E.M. *p&lt;0.05</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.008">http://dx.doi.org/10.7554/eLife.18206.008</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig3-figsupp1-v1"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.009</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Correlation between lean mass and oxygen consumption after eight weeks of training.</title><p>(<bold>A</bold>) Correlation plots in all trained mice (combined Control-Train and VMH<sup>∆SF-1</sup>-Train mice) three days following the last training session, and (<bold>B</bold>) the corresponding correlation plots of trained mice separated by genotype (Control-Train and VMH<sup>∆SF-1</sup>-Train mice).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.009">http://dx.doi.org/10.7554/eLife.18206.009</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig3-figsupp2-v1"/></fig></fig-group></p></sec><sec id="s2-3"><title>Deletion of SF-1 in the VMH blunts metabolic adaptations of skeletal muscle in response to exercise</title><p>Many studies have shown that lean mass is correlated with resting metabolic rate (<xref ref-type="bibr" rid="bib40">Müller et al., 2002</xref>; <xref ref-type="bibr" rid="bib60">Tschöp et al., 2012</xref>). While lean mass was significantly correlated with oxygen consumption in all genotypes (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), we unexpectedly found that exercised-VMH<sup>∆SF-1</sup> mice had significantly less lean mass compared to exercised-control mice (<xref ref-type="fig" rid="fig3">Figure 3F–H</xref>). These results suggest that the reduction in lean mass may underlie the failure of VMH<sup>∆SF-1</sup> mice to increase energy expenditure in response to exercise. Moreover, this reduction may also blunt other beneficial effects of exercise. Predictably, we found that exercise-induced increases in relative skeletal muscle mass (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>) in control mice. The improvements in relative skeletal muscle mass (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>), body composition, and circulating glucose levels were impaired in VMH<sup>∆SF-1</sup> mice compared to control mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).<fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.18206.010</object-id><label>Figure 4.</label><caption><title>Deletion of SF-1 in the VMH blunts skeletal muscle adaptations to exercise training.</title><p>(<bold>A–D</bold>) Following four weeks of exercise training, muscle weights for (<bold>A</bold>) soleus, (<bold>B</bold>) gastrocnemius, (<bold>C</bold>) tibialis anterior (TA), and (<bold>D</bold>) extensor digitorum longus (EDL) from sedentary (Control-Sed and VMH<sup>∆SF-1</sup>-Sed) or exercised (Control-Train and VMH<sup>∆SF-1</sup>-Train) mice were determined. Tissues were collected 72 hr after the last bout of exercise. The same exercise regime as described in <xref ref-type="fig" rid="fig2">Figure 2</xref> (see also <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>) was used. (<bold>E–J</bold>) Tibialis anterior muscles were analyzed from mice two hours following a single exercise session (Control-Run and VMH<sup>∆SF-1</sup>-Run) and from time-matched sedentary controls (Control-Sed and VMH<sup>∆SF-1</sup>-Sed) to determine (<bold>E</bold>) phosphorylation of CREB Ser 133 (pCREB<sup>Ser133</sup>) levels, and mRNA levels for <italic>Ppargc1a</italic> (PGC-1α) isoforms: (<bold>F</bold>) total, (<bold>G</bold>) α−1, (<bold>H</bold>) α−2, (<bold>I</bold>) α−3, and (<bold>J</bold>) α−4. All mice were fed chow diet. Values are mean ± S.E.M. *p&lt;0.05.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.010">http://dx.doi.org/10.7554/eLife.18206.010</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig4-v1"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.011</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Deletion of SF-1 in the VMH blunts improvement in body composition and glycemia of chow-fed mice in response to exercise training.</title><p>(<bold>A</bold>) Weekly body weight, (<bold>B</bold>) the change (Δ) in body weight between baseline (week 0) to post-exercise training (week 4), (<bold>C</bold>) body composition, (<bold>D</bold>) lean mass, (<bold>E</bold>) fat mass, and (<bold>F</bold>) glucose levels in the blood after four weeks of exercise training in control and VMH<sup>∆SF-1</sup> mice. The same exercise regimen described in <xref ref-type="fig" rid="fig1">Figure 1</xref> was used. All mice were fed with chow diet. For body composition (<bold>A</bold>), † indicates statistical analysis for % fat mass. Values are mean ± S.E.M. ***p&lt;0.001, *p&lt;0.05 and †††p&lt;0.001, †p&lt;0.05.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.011">http://dx.doi.org/10.7554/eLife.18206.011</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig4-figsupp1-v1"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.012</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Deletion of SF-1 in the VMH blunts sympathetic drives to the adrenal gland.</title><p>Circulating (<bold>A</bold>) epinephrine, (<bold>B</bold>) norepinephrine, (<bold>C</bold>) insulin, and (<bold>D</bold>) glucagon levels immediately after exercise. (<bold>E</bold>) pre-mRNA levels of tyrosine hydroxylase (TH) in the adrenal gland 2 hr after a single bout of exercise. All mice were fed with chow diet. Values are mean ± S.E.M. **p&lt;0.01, *p&lt;0.05</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.012">http://dx.doi.org/10.7554/eLife.18206.012</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig4-figsupp2-v1"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.013</object-id><label>Figure 4—figure supplement 3.</label><caption><title>Deletion of SF-1 in the VMH does not affect mRNA levels of adrenergic receptors in the skeletal muscle.</title><p>mRNA expression levels of (<bold>A</bold>) <italic>Adra1a</italic>, (<bold>B</bold>) <italic>Adra1b,</italic> (<bold>C</bold>) <italic>Adra1d</italic>, (<bold>D</bold>) <italic>Adra2a,</italic> (<bold>E</bold>) <italic>Adra2b</italic>, (<bold>F</bold>) <italic>Adra2c</italic>, (<bold>G</bold>) <italic>Adrb1</italic>, and (<bold>H</bold>) <italic>Adrab2</italic>, in TA muscle 2 hr after one bout of exercise. <italic>Adrb3</italic> mRNA was not detectable in TA muscle. Values are mean ± S.E.M. **p&lt;0.01, *p&lt;0.05</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.013">http://dx.doi.org/10.7554/eLife.18206.013</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig4-figsupp3-v1"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.014</object-id><label>Figure 4—figure supplement 4.</label><caption><title>Deletion of SF-1 in the VMH does not affect the mTOR and AKT signaling pathways in TA skeletal muscle in response to exercise training or acute exercise.</title><p>Phosphorylation of (<bold>A</bold>) P70S6K (Thr 389), (<bold>B</bold>) 4EBP1 (Thr37/46), (<bold>C</bold>) mTOR (Ser 2448) levels in TA muscle 2 hr after one bout of exercise. (<bold>D</bold>) Representative immunoblots for (<bold>A–C</bold>). (<bold>E</bold>) AKT (Thr308), (<bold>F</bold>) ACC (Ser79), (<bold>G</bold>) AMPK (Thr172) levels in TA muscle 2 hr after one bout of exercise. (<bold>H</bold>) Representative immunoblots for (<bold>E–G</bold>). Values are mean ± S.E.M. *p&lt;0.05</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.014">http://dx.doi.org/10.7554/eLife.18206.014</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig4-figsupp4-v1"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.18206.015</object-id><label>Figure 4—figure supplement 5.</label><caption><title>Deletion of SF-1 in the VMH alters mRNA levels of genes regulating protein turnover in the skeletal muscle.</title><p>mRNA expression levels of (<bold>A</bold>) <italic>Nr4a2</italic>, (<bold>B</bold>) <italic>Crem,</italic> (<bold>C</bold>) <italic>Foxo1</italic>, (<bold>D</bold>) <italic>Smad3,</italic> (<bold>E</bold>) <italic>Myog</italic>, (<bold>F</bold>) <italic>Myod1</italic>, (<bold>G</bold>) <italic>Fbxo32</italic>, and (<bold>H</bold>) <italic>Ctsl</italic>, in TA muscle 2 hr after one bout of exercise. Values are mean ± S.E.M. ****p&lt;0.001, p&lt;0.001, **p&lt;0.01, *p&lt;0.05</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.015">http://dx.doi.org/10.7554/eLife.18206.015</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-18206-fig4-figsupp5-v1"/></fig></fig-group></p><p>A number of studies have demonstrated that the VMH regulates the sympathetic nervous system (SNS) (<xref ref-type="bibr" rid="bib30">King, 2006</xref>; <xref ref-type="bibr" rid="bib41">Niijima et al., 1984</xref>), including altering substrate utilization by skeletal muscle (<xref ref-type="bibr" rid="bib21">Haque et al., 1999</xref>; <xref ref-type="bibr" rid="bib53">Shiuchi et al., 2009</xref>). To assess whether deletion of SF-1 in the VMH alters sympathetic nervous system activity in response to exercise, we measured circulating catecholamines immediately after a single bout of exercise. Circulating levels of norepinephrine, glucagon and insulin were not significantly different between groups (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B–D</xref>). Notably, circulating epinephrine levels in exercised-VMH<sup>∆SF-1</sup> mice were significantly lower than those of exercised-control mice (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). We also measured levels of tyrosine hydroxylase (TH) pre-mRNA (intronic mRNA) in the adrenal gland as a surrogate marker of sympathetic nervous system activity (<xref ref-type="bibr" rid="bib66">Yamamoto et al., 2002</xref>, <xref ref-type="bibr" rid="bib65">2003</xref>). Interestingly, a single bout of exercise increased <italic>Th</italic> pre-mRNA levels in the adrenal gland of control mice. In contrast, deletion of SF-1 in the VMH blunted these responses (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E</xref>). These data are consistent with the model that sympathetic nervous system activation in response to exercise is blunted in VMH<sup>∆SF-1</sup> mice.</p><p>Pharmacological stimulation of β2-adrenergic receptor (β2AdR, the major isoform in skeletal muscle) can increase skeletal muscle mass by both promoting protein synthesis and suppressing protein degradation (<xref ref-type="bibr" rid="bib36">Lynch and Ryall, 2008</xref>). Notably, β2AdR stimulation increases skeletal muscle mass, which are predominantly composed of fast-twitch fibers (<xref ref-type="bibr" rid="bib36">Lynch and Ryall, 2008</xref>). Interestingly, deletion of SF-1 in the VMH affected the size of the tibialis anterior (TA), gastrocnemius and the extensor digitorum longus (EDL) muscles (<xref ref-type="fig" rid="fig4">Figure 4B-D</xref>) which are predominantly composed of fast-twitch fibers in mice (<xref ref-type="bibr" rid="bib12">Diffee et al., 2002</xref>; <xref ref-type="bibr" rid="bib57">Taylor et al., 2008</xref>). Treatment with a β2AdR agonist leads to phosphorylation of cAMP response element binding protein (pCREB) (<xref ref-type="bibr" rid="bib32">Koopman et al., 2010</xref>; <xref ref-type="bibr" rid="bib36">Lynch and Ryall, 2008</xref>), which can bind to the peroxisome proliferator-activated receptor gamma co-activator 1-alpha (PGC-1α; <italic>Ppargc1a</italic>) promoter to regulate various transcriptional events (<xref ref-type="bibr" rid="bib17">Fernandez-Marcos and Auwerx, 2011</xref>). This pathway is thought to contribute to the numerous adaptive responses to exercise (<xref ref-type="bibr" rid="bib20">Handschin and Spiegelman, 2008</xref>) including altered protein synthesis and degradation (<xref ref-type="bibr" rid="bib5">Bruno et al., 2014</xref>; <xref ref-type="bibr" rid="bib46">Ruas et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Sandri et al., 2006</xref>).</p><p>As training adaptations are the cumulative effect of multiple individual exercise bouts (<xref ref-type="bibr" rid="bib22">Hawley et al., 2014</xref>), we focused instead on the effect of a single bout of exercise (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>) on skeletal muscle signaling pathways. We found that SF-1 deletion in the VMH blunted phosphorylation of CREB (pCREB) in skeletal muscle following acute exercise (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). However, skeletal muscle mRNA levels of the adrenergic receptor (AdR) subtypes did not differ between control and VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). The mammalian target of rapamycin (mTOR) signaling pathway regulates protein synthesis/degradation and can be activated by β2AdR signaling (<xref ref-type="bibr" rid="bib36">Lynch and Ryall, 2008</xref>). Phosphorylated proteins in the mTOR pathway were comparable between exercised-control and -VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4A–D</xref>). Moreover, phosphorylation of AKT, ACC and AMPK were also comparable between control and VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4E–H</xref>). Additionally, <italic>Nr4a2, Crem, Foxo1,</italic> and <italic>Smad3</italic>, which are known to be altered by catecholamines (<xref ref-type="bibr" rid="bib62">Viguerie et al., 2004</xref>), β2AdR-agonist injection (<xref ref-type="bibr" rid="bib43">Pearen et al., 2009</xref>), and exercise (<xref ref-type="bibr" rid="bib6">Catoire et al., 2012</xref>; <xref ref-type="bibr" rid="bib15">Egan et al., 2013</xref>). However, the mRNA levels of these genes were not statistically different between control and VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5A–D</xref>).</p><p>As expected, control mice showed a significant increase in mRNA expression of total <italic>Ppargc1a</italic> and each of the <italic>Ppargc1a</italic> isoforms, including <italic>Ppargc1a</italic>-4, after acute exercise (<xref ref-type="fig" rid="fig4">Figure 4F–J</xref>). For example, PGC-1α-4 has been predicted to contribute to skeletal muscle adaptations following exercise (<xref ref-type="bibr" rid="bib46">Ruas et al., 2012</xref>). We found that exercise-induced expression of total <italic>Ppargc1a</italic> and <italic>Ppargc1a</italic>-2 in muscle was blunted in VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). PGC-1α-2 was impaired in exercised-VMH<sup>∆SF-1</sup> mice, suggesting that the reduction in total <italic>Ppargc1a</italic> expression levels is due to changes in <italic>Ppargc1a</italic>-2 (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). We also examined mRNA expression levels of <italic>Myog, Myod1, Fbxo32,</italic> and <italic>Ctsl</italic>, all of which regulate protein synthesis and degradation (<xref ref-type="bibr" rid="bib35">Liu et al., 2010</xref>; <xref ref-type="bibr" rid="bib51">Sandri et al., 2006</xref>). While acute exercise did not significantly alter these genes in control mice; exercised-VMH<sup>∆SF-1</sup> mice had increased levels of <italic>Myog</italic> and <italic>Fbxo32</italic> (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5E–H</xref>). These findings suggest that deletion of SF-1 in the VMH may affect protein turnover in the skeletal muscle in response to exercise. While the physiological role of PGC-1α-2 is still unclear, we speculate that it may be important for regulating protein turnover in response to sympathetic input from the CNS following exercise.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our current results coupled with previous observations (<xref ref-type="bibr" rid="bib9">Choi et al., 2013</xref>; <xref ref-type="bibr" rid="bib28">Kim et al., 2011b</xref>; <xref ref-type="bibr" rid="bib45">Ramadori et al., 2011</xref>; <xref ref-type="bibr" rid="bib58">Tong et al., 2007</xref>; <xref ref-type="bibr" rid="bib64">Xu et al., 2010</xref>) suggest that SF-1 in the VMH is required for metabolic adaptations. In particular, our date supports a model predicting that SF-1 in the VMH is required for the metabolic adaptations to exercise training, including increasing metabolic rate, skeletal muscle mass, and decreased adiposity. Previous lines of evidence also support a role for the VMH in regulating the metabolic responses to exercise. For example, stimulation of the VMH enhances lipolysis in white adipose tissues and facilitates fatty acid oxidation (<xref ref-type="bibr" rid="bib47">Ruffin and Nicolaidis, 1999</xref>; <xref ref-type="bibr" rid="bib54">Takahashi and Shimazu, 1981</xref>). Blockade of β-adrenergic receptors (βAdRs) in the VMH impedes the increase in circulating fatty acids during exercise (<xref ref-type="bibr" rid="bib52">Scheurink et al., 1988</xref>). Moreover, microinjections of the anesthetic lidocaine or βAdR antagonists into the VMH inhibits fatty acid oxidation during exercise (<xref ref-type="bibr" rid="bib38">Miyaki et al., 2011</xref>). Of note, suppression of neuronal activity in the VMH apparently does not affect metabolism under sedentary conditions (<xref ref-type="bibr" rid="bib38">Miyaki et al., 2011</xref>; <xref ref-type="bibr" rid="bib54">Takahashi and Shimazu, 1981</xref>). Collectively, our findings indicate that SF-1 in the VMH is required for the full adaptive response to exercise training.</p><p>A large body of literature suggests that the VMH regulates the SNS in order to enhance lipolysis, fatty acid oxidation, and glucose uptake in peripheral tissues (<xref ref-type="bibr" rid="bib1">Adler et al., 2012</xref>; <xref ref-type="bibr" rid="bib2">Bamshad et al., 1999</xref>; <xref ref-type="bibr" rid="bib21">Haque et al., 1999</xref>; <xref ref-type="bibr" rid="bib30">King, 2006</xref>; <xref ref-type="bibr" rid="bib37">Minokoshi et al., 1999</xref>; <xref ref-type="bibr" rid="bib41">Niijima et al., 1984</xref>; <xref ref-type="bibr" rid="bib44">Perkins et al., 1981</xref>; <xref ref-type="bibr" rid="bib48">Sakaguchi and Bray, 1987a</xref>, <xref ref-type="bibr" rid="bib49">1987b</xref>; <xref ref-type="bibr" rid="bib50">Sakaguchi et al., 1988</xref>; <xref ref-type="bibr" rid="bib54">Takahashi and Shimazu, 1981</xref>, <xref ref-type="bibr" rid="bib55">1982</xref>). For instance, microinjection of leptin or orexin into the VMH increases glucose uptake in skeletal muscle via the SNS (<xref ref-type="bibr" rid="bib21">Haque et al., 1999</xref>; <xref ref-type="bibr" rid="bib53">Shiuchi et al., 2009</xref>). Although the precise circuitry downstream of the VMH remains to be determined, genetic tracing has revealed that SF-1 neurons project to regions of the brain that control activity of the autonomic nervous system including the parabrachial nucleus, nucleus of the solitary tract and the rostral ventrolateral medulla (<xref ref-type="bibr" rid="bib34">Lindberg et al., 2013</xref>). Interestingly, a recent study demonstrated that optogenetic photostimulation of SF-1 neurons rapidly alters heart rate (<xref ref-type="bibr" rid="bib63">Wang et al., 2015</xref>), further suggesting that SF-1 may regulate autonomic function. Collectively, these studies suggest that SF-1 neurons act on the SNS to regulate metabolism in the skeletal muscle and other peripheral tissues, and impaired SNS activity may underlie the blunted response in adiposity, skeletal muscle and metabolic rate to exercise training in VMH<sup>∆SF-1</sup> mice.</p><p>Adrenergic receptors in skeletal muscle, including βAdR2, have been investigated as potential pharmacological targets for the treatment of muscle wasting and weakness. Administration of βAdR2 agonists regulates multiple signaling pathways, including PKA and PI3K, to increase skeletal muscle mass by coordinating protein synthesis and degradation (<xref ref-type="bibr" rid="bib36">Lynch and Ryall, 2008</xref>). Our data indicate that deletion of SF-1 in the VMH specifically attenuates the activation of CREB, a downstream signaling target of PKA, in skeletal muscle following exercise (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Intriguingly, CREB can regulate the expression levels of PGC-1α, a major regulator of skeletal muscle oxidative function and a potential regulator of muscle growth (<xref ref-type="bibr" rid="bib20">Handschin and Spiegelman, 2008</xref>; <xref ref-type="bibr" rid="bib46">Ruas et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Sandri et al., 2006</xref>). In line with this, we observed attenuated pCREB in the skeletal muscles of exercised-VMH<sup>∆SF-1</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). We also found that VMH<sup>∆SF-1</sup> mice had reductions in exercise-induced PGC-1α expression, in particular the PGC-1α-2 isoform (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Although the precise role of skeletal muscle PGC-1α-2 in the regulation of metabolism has not yet been determined (<xref ref-type="bibr" rid="bib10">Correia et al., 2015</xref>; <xref ref-type="bibr" rid="bib46">Ruas et al., 2012</xref>), these data imply that isoform specific regulation may contribute to metabolic adaptations to exercise.</p><p>Recent in vitro studies and structural analysis studies have suggested that several molecules involved in PI3K signaling pathway may interact with SF-1 to modulate its function (<xref ref-type="bibr" rid="bib4">Blind et al., 2012</xref>, <xref ref-type="bibr" rid="bib3">2014</xref>; <xref ref-type="bibr" rid="bib28">Kim et al., 2011b</xref>). Forkhead box protein O1 (Foxo1) is a terminal downstream molecule of the PI3K signaling pathway, and is translocated from the nucleus to cytosol upon PI3K activation (<xref ref-type="bibr" rid="bib61">Van Der Heide et al., 2004</xref>). Interestingly, we previously found that deletion of Foxo1 in the VMH increases SF-1 mRNA levels in the hypothalamus (<xref ref-type="bibr" rid="bib25">Kim et al., 2012</xref>), suggesting that PI3K signaling regulates SF-1 expression levels in the VMH in vivo. While studies suggest that exercise can activate PI3K signaling in the hypothalamus after exercise training (<xref ref-type="bibr" rid="bib8">Chiarreotto-Ropelle et al., 2013</xref>; <xref ref-type="bibr" rid="bib67">Zhao et al., 2011</xref>), it remains unclear whether this occurs specifically in SF-1 neurons. Exercise training also increases several neurotrophic factors in the hippocampus, including BDNF, which activate the PI3K signaling pathway (<xref ref-type="bibr" rid="bib11">Cotman et al., 2007</xref>). Exercise has been shown to induce BDNF levels in the mediobasal hypothalamus (<xref ref-type="bibr" rid="bib56">Takimoto and Hamada, 2014</xref>). In addition, we demonstrated that exercise training can increase mRNA expression of SF-1 and putative SF-1 target genes in the mediobasal hypothalamus (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). These studies support a model predicting exercise increases the activity of PI3K signaling pathways in the hypothalamus (including VMH neurons), which modulates the SF-1 activity and increases expression of SF-1 target genes. Future studies will test distinct components of this model.</p><p>Exercise is known to have beneficial effects on metabolism in both healthy and overweight individuals. However, the ability to exercise is often hindered by physical ailments or time constraints associated with our modern lifestyle. Unraveling the neuronal mechanisms underlying the metabolic adaptations in response to exercise is key for understanding the beneficial effects of exercise on overall health, and may facilitate the development of new therapeutic strategies to combat the effects of obesity, diabetes, and associated metabolic diseases.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals and treadmill exercise</title><p>To generate mice lacking SF-1 only in the VMH, mice expressing the floxed <italic>Nr5a1</italic> allele (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007042">IMSR_JAX:007042</ext-link>) were crossed with <italic>Camk2a</italic>-Cre (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_EM:01137">IMSR_EM:01137</ext-link>) mice as previously described (<xref ref-type="bibr" rid="bib28">Kim et al., 2011b</xref>). Littermate mice that were homozygous for the <italic>Nr5a1</italic> allele, but without the <italic>Camk2a</italic>-Cre allele, served as controls. All experiments were performed with 8–12 weeks of age male mice, unless otherwise stated. A 6-lane motorized treadmill apparatus (Columbus, OH, US) was used for exercise training. Care of mice was within the Institutional Animal Care and Use Committee (IACUC) guidelines, and all the procedures were approved by the University of Texas Southwestern Medical Center IACUC.</p><p>Mice were housed at room temperature (22–24°C) with a 12 hr light/dark cycle (lights on at 6am, and 7am during daylight saving time) and fed with normal mouse chow diet (Harlan, Teklad Global 16% Protein Rodent Diet 2016; 12% kcal from fat, 3 kcal/g) or high fat diet (Research Diet, #D12492; 60% kcal from fat, 5.24 kcal/g) with water provided ad libitum. Ear DNA was collected from each mouse to determine its genotype. A DNA extraction kit was used for PCR genotyping (KAPA Biosystems, MA, US). Genotyping primers were as follows: for the <italic>Camk2a</italic>-Cre allele (5' ggtcagcctaattagctctgt, 5' gatctccagctcctcctctgtc, 5' gccctggaagggatttttgaagca, and 5' atggctaatcgccatcttccagca), and for the <italic>Nr5a1</italic> floxed allele 5' ccaggaagacaacttctccgtgtg, 5' aaactgtctcagggagaccatgag, 5' tgagatgacaaggagattctgc). C57BL/6J mice were purchased from the Jackson laboratory (8 weeks of age, catalog # 000664)</p></sec><sec id="s4-2"><title>Exercise training protocol</title><p>A 10° treadmill incline was used in all experiments, except for the endurance capacity test. Mice were encouraged to run by electrical shock (0.25 mA × 163 V and 1 Hz). Food was removed from both exercise and sedentary groups 2 hr before each treadmill running session. Water was removed from sedentary groups during the exercise session. Food and water were returned to cages immediately following the exercise session unless otherwise stated.</p><p>For the endurance capacity test, a progressive running paradigm was used (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). On day 1, all mice were acclimated to the treadmill apparatus at a speed of 8 m/min for 5 min. On day 2, all mice ran at 8 m/min for 5 min followed by 10 m/min for 10 min. Acclimated mice were then rested in their home cages on day 3 and 4, and were then randomly assigned to either sedentary or exercise groups. On day 5, mice began the exercise training at a speed of 10 m/min for 40 min. After the initial 40 min, the speed was increased at a rate of 1 m/min every 10 min until the speed reached 13 m/min; at which point, the speed was increased at a rate of 1 m/min every 5 min until all mice were exhausted. Time to exhaustion was defined as the point mice spent more than 5 s on the electrical shocker. Based on data obtained from this endurance test, we chose an exercise intensity that could be sustained by both control and VMH<sup>∆SF-1</sup> mice for our exercise training paradigm (15 m/min for 60 min at a 10˚ incline, 5 days/week).</p><p>A 10° treadmill incline was used in all experiments, except for the endurance capacity test. Mice were encouraged to run by electrical shock (0.25 mA × 163 V and 1 Hz). Food was removed from both exercise and sedentary groups 2 hr before each treadmill running session. Water was removed from sedentary groups during the exercise session. Food and water were returned to cages immediately following the exercise session unless otherwise stated.</p><p>For prolonged training, mice were acclimated starting at week 0 as described in <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>. During this time mice were either maintained on HFD (<xref ref-type="fig" rid="fig2">Figure 2</xref>) or chow (<xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig3">3</xref> and <xref ref-type="fig" rid="fig4">4</xref>). For HFD-fed mice, diet was switched from chow to HFD 1 week prior to exercise training (day 1 of acclimation) and maintained on HFD for the duration of the exercise training period. During week 1 of training, the speed was gradually increased day by day until the speed reached 15 m/min as described in <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>. From the week 2 onwards, mice ran at a speed of 10 m/min for 5 min and the speed was increased at a rate of 1 m/min every 1 min until the speed reached 15 m/min. The speed was maintained for 51 min (total run time is 60 min). The training bouts were performed five days/week (Monday-Friday). The duration of the training sessions is described in each figure legend. 72 hr after the last exercise bout, food was removed from cages 2 hr prior to blood and tissue collection.</p></sec><sec id="s4-3"><title>Assessment of heart function by echocardiography</title><p>Echocardiograms were performed on conscious, gently restrained mice using either a Sonos 5500 system with a 15-MHz linear probe or a Vevo 2100 system with a MS400C scanhead. Left ventricular end diastolic diameter (LVEDD) and left ventricular end systolic diameter (LVESD) were measured from M-mode recordings.</p></sec><sec id="s4-4"><title>Assessment of mitochondrial function</title><p>To determine mitochondrial function in TA muscle, oxygen consumption rates (OCRs) in isolated mitochondria from TA muscle were determined using the XF24 Extracellular Flux Analyzer (Seahorse Bioscience, MA) as previously described (<xref ref-type="bibr" rid="bib33">Kusminski et al., 2012</xref>). To isolate mitochondria, TA skeletal muscle tissues were homogenized using a motorized Dounce homogenizer in ice-cold MSHE buffer (70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 1 mM EDTA) containing 0.5% FA-free BSA. Homogenates then underwent low centrifugation (800 g for 10 min) to remove nuclei and cell debris, followed by high centrifugation (8000 g for 10 min) to obtain the mitochondrial pellet, which was washed once in ice-cold MSHE buffer and was resuspended in a minimal amount of MSHE buffer prior to determination of protein concentrations using a BCA assay (Life technology). Oxygen consumption rates (OCRs) were determined using the XF24 Extracellular Flux Analyzer (Seahorse Bioscience, MA) following the manufacturers’ protocols. For the electron-flow (EF) experiments, isolated TA skeletal muscle mitochondria were seeded at 10 μg of protein per well in XF24 V7 cell-culture microplates (Seahorse Bioscience), then pelleted by centrifugation (2000 g for 20 min at 4°C) in 1X MAS buffer (70 mM sucrose, 220 mM mannitol, 10 mM KH<sub>2</sub>PO<sub>4</sub>, 5 mM MgCl<sub>2</sub>, 2 mM HEPES, 1 mM EGTA in 0.2% FA-free BSA; pH 7.2) supplemented with 10 mM pyruvate, 10 mM malate and 4 μM carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) (for EF experiments), with a final volume of 500 μl per well. For electron-coupling (EC) experiments, 1X MAS buffer was supplemented with 10 mM succinate and 2 μM rotenone. The XF24 plate was then transferred to a temperature-controlled (37°C) Seahorse analyzer and subjected to a 10 min equilibration period and two assay cycles to measure the basal rate, comprising a 30 s mix, and a 3 min measure period each; and compounds were added by automatic pneumatic injection followed by a single assay cycle after each; comprising a 30 s mix and 3 min measure period. For EF experiments, OCR measurements were obtained following sequential additions of rotenone (2 μM final concentration), succinate (10 mM), antimycin A (4 μM) and ascorbate (10 mM) (the latter containing 1 mM N,N,N',N'-tetramethyl-p-phenylenediamine [TMPD]). For EC experiments, OCR measurements were obtained post sequential additions of ADP (4 mM), oligomycin (2 μM), FCCP (4 μM) and antimycin-A (2 μM). OCR measurements were recorded at set interval time-points.</p></sec><sec id="s4-5"><title>Assessment of lipid metabolism and glucose levels in the blood</title><p>Glucose was measured using a commercially available glucose meter (Bayer's Contour Blood Glucose Monitoring System; Leverkusen, Germany). Blood was collected in EDTA tubes and plasma was isolated by centrifugation (3000 g × 20 min at 4°C) and stored at −80°C. Free fatty acid species were quantified by shotgun lipidomics. Using an ABI 5600+ (AB Sciex, Gramingham, MA), we simultaneously identified changes in hundreds of distinct lipid species via a nonbiased approach following direct infusion of extracted lipids containing 18 mM ammonium fluoride to aid in ionization of neutral lipids and to reduce salt adducts. Data from the AB Sciex 5600+ was collected and calibrated with Analyst and PeakView Software (AB Sciex, Framingham, MA).</p></sec><sec id="s4-6"><title>Assessment of catecholamines and hormone levels in the blood</title><p>To measure epinephrine and norepinephrine in the blood, an EGTA-Glutathione solution (9% w/v EGTA and 6% w/v Glutathione, pH 7.4; 2 μL per 100 μL blood) was added to the blood collected in EDTA tubes. To measure glucagon in the blood, Aprotinin saline solution (Sigma, US) was added (7.5 μL per 100 μL blood) to EDTA tubes. Plasma was isolated by centrifugation (3000 g × 20 min at 4°C) and stored at −80°C. The plasma samples were analyzed by the Vanderbilt Hormone Assay and Analytical Services Core. To measure insulin in the blood, blood was collected in EDTA tubes, and plasma was isolated by centrifugation (3000 g × 20 min at 4°C) and stored at −80°C. Insulin levels were determined by a commercially available ELISA kit (Crystal Chem Inc, US)</p></sec><sec id="s4-7"><title>Metabolic cage studies</title><p>A combined indirect calorimetry system (CaloSys Calorimetry System, TSE Systems Inc, Bad Homburg, Germany) was used for all metabolic studies. During the exercise training period, mice either remained sedentary (Control-Sed and VMH<sup>∆SF-1</sup>-Sed) or exercised (Control-Run and VMH<sup>∆SF-1</sup>-Run) and were housed together before being placed in metabolic cages. Experimental animals were acclimated for five days in a metabolic chamber with food and water. Room temperature for all metabolic studies was maintained at 23°C with a 12 hr light/dark cycle. Heat generation, O<sub>2</sub> consumption, and CO<sub>2</sub> production were measured after acclimation and the relationship between metabolic rate and body mass was normalized by lean mass. During this time, ambulatory movement was also monitored with infrared beams.</p></sec><sec id="s4-8"><title>Assessment of mRNA</title><p>mRNA levels in the TA muscle were determined as previously described with slight modifications (<xref ref-type="bibr" rid="bib18">Fujikawa et al., 2010</xref>). RNA was extracted using STAT60 reagent (Amsbio, MA, USA). Complementary DNA from 1 μg of input RNA was generated with the High Capacity cDNA Reverse Transcription Kits (Life Technologies). SYBR Green PCR master mix (Life Technologies) was used for the quantitative real time PCR analysis of all genes, except for <italic>Ppargc1α−4</italic>, which was detected with Fast SYBR Green PCR mix (KAPA Biosystems). The sequences of the deoxy-oligonucleotides primers are: pre-mRNA <italic>Th</italic> (5' caggacccaacagaagcatt and 5' cctagggttggagtgggtct) <italic>Ppargc1a</italic> total (5' tgatgtgaatgacttggatacagaca, and 5' gctcattgttgtactggttggatatg), <italic>Ppargc1a</italic>-<italic>1</italic> (5' ggacatgtgcagccaagactct, and 5' cacttcaatccacccagaaagct), <italic>Ppargc1a</italic>-<italic>2</italic> (5' ccaccagaatgagtgacatgga, and 5' gttcagcaagatctgggcaaa), <italic>Ppargc1a</italic>-<italic>3</italic> (5' aagtgagtaaccggaggcattc, and 5' ttcaggaagatctgggcaaaga), <italic>Ppargc1a</italic>-<italic>4</italic> (5' tcacaccaaacccacagaaa, and 5' ctggaagatatggcacat), and <italic>18S</italic> (5' catgcagaacccacgacagta and 5' cctcacgcagcttgttgtcta). Taqman probes were used for detecting following genes: SF-1 (<italic>Nr5a1</italic>; Mm00446826_m1), <italic>Bdnf</italic> (Mm01334047_m1), <italic>Cnr1</italic> (Mm00432621_s1), <italic>Crhr2</italic> (Mm00438303_m1), <italic>Adra1a</italic> (Mm00442668_m1), <italic>Adra1b</italic> (Mm00431685_m1), <italic>Adra1d</italic> (Mm01328600_m1), <italic>Adra2a</italic> (Mm00845383_s1), <italic>Adra2b</italic> (Mm00477390_s1), <italic>Adra2c</italic> (Mm00431686_s1), <italic>Adrb1</italic> (Mm00431701_s1), <italic>Adrb2</italic> (Mm02524224_s1), <italic>Adrb3</italic> (Mm02601819_g1), <italic>Nr4a2</italic> (Mm00443060_m1), <italic>Crem</italic> (Mm04336053_g1), <italic>Foxo1</italic> (Mm00490672_m1), <italic>Smad3</italic> (Mm01170760_m1), <italic>Myog</italic> (Mm00446195_g1), <italic>Myod1</italic> (Mm01203489_g1), <italic>Fbxo32</italic> (Mm00499523_m1), <italic>Ctsl</italic> (Mm00515597_m1), and <italic>18S</italic> (Hs99999901_s1).</p></sec><sec id="s4-9"><title>Assessment of protein contents</title><p>Frozen TA muscles from mice were powdered in liquid nitrogen, weighed and put into tubes that contain 1.4 mm ceramic spheres (Lysing Matrix D; MP biomedical, CA, USA). Ice cold lysis buffer was composed of RIPA buffer (Sigma), 1% (v/v) of protease inhibitor cocktail (P8340-5ML, Sigma), phosphatase inhibitors cocktail 2 and 3 (P5726-5ML and P0044-5ML from Sigma). The samples were homogenized for 30 s x 6000 rpm. After homogenization, the samples were solubilized by constant rotation for 1 hr at 4°C. The samples were then transferred to a new 1.5 ml tube and centrifuged for 10 min x 10,000 <italic>g</italic> at 4°C. The supernatant was carefully pipetted into a new tube and the protein concentration was measured via BCA protein assay (Life Technologies, NY, US). The samples were then stored at −80°C until further analysis. Equal amounts of total protein (40 µg) per sample were diluted with appropriate volume of laemmle sample buffer (2X concentrated; 4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.004% bromophenol blue and 0.125 M pH6.8 Tris-HCl) heated for 5 min at 95°C, separated via SDS-PAGE 4–15% Tris-HCl gels (Bio-Rad, Hercules, CA), and transferred to nitrocellulose (Trans-blot turbo, Bio-Rad, Hercules, CA). Membranes were incubated with the appropriate primary (pCREB; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_331275">AB_331275</ext-link>, pmTOR; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330970">AB_330970</ext-link>, p-P70S6K; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2269803">AB_2269803</ext-link>, and p4EBP1; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_560835">AB_560835</ext-link>, pAKT; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2255933">AB_2255933</ext-link>, pACC; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330337">AB_330337</ext-link>, pAMPK; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_330330">AB_330330</ext-link>, CREB; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1903940">AB_1903940</ext-link>, Cell Signaling Technologies, Danvers, MA; Tubulin; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_305328">AB_305328</ext-link>, Lot 750270, Abcam, Cambridge, MA) and florescent secondary antibodies (IRDye 680 Goat anti-Mouse IgG; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_621840">AB_621840</ext-link>, and IRDye 800CW Goat anti-Rabbit IgG; RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_621843">AB_621843</ext-link>, Li-Cor Bioscience, Lincoln, NB). Protein band fluorescence was quantified via Li-Cor Odessy Image studio Version 4.0 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014579">SCR_014579</ext-link>, Li-Core Bioscience, Lincoln, NB). Individual values are relative to the mean of the sedentary control value within the same membrane, and equal loading was confirmed via immuno-reactivity of tubulin.</p></sec><sec id="s4-10"><title>Data analysis</title><p>The data are represented as either mean or means ± S.E.M. as indicated in each figure legend. Statistical significance was determined by unpaired t-test or two-way ANOVA followed by one-way ANOVA (Tukey’s Multiple Comparison Test if the interaction was significant) or unpaired t-test in the same factor (if the interaction was not significant). A detailed analysis of all data was described in <xref ref-type="supplementary-material" rid="SD1-data">Supplementary file 1</xref>. GraphPad PRISM, version 6 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link>, GraphPad, San Diego, CA) was used for the statistical analyses and p&lt;0.05 was considered as a statistically significant difference.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank the Mouse Metabolic Phenotyping Core at UT Southwestern Medical Center at Dallas. The Vanderbilt Hormone Assay and Analytical Services Core are supported by the National Institutes of Health (NIH) grants DK059637 and DK020593. This study was supported by the American Heart Association (Scientist Development Grant 14SDG17950008 to TF and 14SFRN20740000 to JAH), the National Research Foundation (NRF-2013R1A1A1007693 to KWK), the Cancer Prevention Research Institute of Texas (RP110486P3 to JAH), the Leducq Foundation (11CVD04 to JAH) and the NIH (F32 DK104659 to CMC, HL-120732 and HL-100401 to JAH, R00DK094973 to WLH, R01 DK100659 to JKE, and P01 DK088761 to PES and JKE). The authors do not have any conflicts of interest.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf2"><p>JKE: Reviewing editor, <italic>eLife</italic> </p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>TF, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>CMC, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>MP, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con4"><p>CMK, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con5"><p>NA, Assisted in experiements, Acquisition of data</p></fn><fn fn-type="con" id="con6"><p>PKB, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con7"><p>KWK, Generated mice</p></fn><fn fn-type="con" id="con8"><p>SL, Assist experimental design and edit manuscript</p></fn><fn fn-type="con" id="con9"><p>JAH, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con10"><p>PES, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con11"><p>WLH, Conception and design, Acquisition of data, Analysis and interpretation of data</p></fn><fn fn-type="con" id="con12"><p>JKE, Conception and design, Analysis and interpretation of data, Drafting or revising the article</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: As described in the Materials and Methods section, care of mice was within the Institutional Animal Care and Use Committee (IACUC) guidelines, and all the procedures were approved by the University of Texas Southwestern Medical Center IACUC. The approved UTSW internal animal protocol numbers are 2008-0070 and 2015-101140.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.18206.016</object-id><label>Supplementary file 1.</label><caption><title>The detailed statistical analysis of figures.The table shows the statistics test, number of N, comparison, p value, and degrees of freedom and F/t/z/R/ETC value in each figure panel.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18206.016">http://dx.doi.org/10.7554/eLife.18206.016</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-18206-supp1-v1.xlsx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>ES</given-names></name><name><surname>Hollis</surname><given-names>JH</given-names></name><name><surname>Clarke</surname><given-names>IJ</given-names></name><name><surname>Grattan</surname><given-names>DR</given-names></name><name><surname>Oldfield</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neurochemical characterization and sexual dimorphism of projections from the brain to abdominal and subcutaneous white adipose tissue in the rat</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>15913</fpage><lpage>15921</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2591-12.2012</pub-id><pub-id pub-id-type="pmid">23136429</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamshad</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>CK</given-names></name><name><surname>Bartness</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>CNS origins of the sympathetic nervous system outflow to brown adipose tissue</article-title><source>The American Journal of Physiology</source><volume>276</volume><fpage>R1569</fpage><lpage>R1578</lpage><pub-id pub-id-type="pmid">10362733</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blind</surname><given-names>RD</given-names></name><name><surname>Sablin</surname><given-names>EP</given-names></name><name><surname>Kuchenbecker</surname><given-names>KM</given-names></name><name><surname>Chiu</surname><given-names>H-J</given-names></name><name><surname>Deacon</surname><given-names>AM</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Fletterick</surname><given-names>RJ</given-names></name><name><surname>Ingraham</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The signaling phospholipid PIP 3 creates a new interaction surface on the nuclear receptor SF-1</article-title><source>PNAS</source><volume>111</volume><fpage>15054</fpage><lpage>15059</lpage><pub-id pub-id-type="doi">10.1073/pnas.1416740111</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blind</surname><given-names>RD</given-names></name><name><surname>Suzawa</surname><given-names>M</given-names></name><name><surname>Ingraham</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Direct modification and activation of a nuclear receptor-PIP₂ complex by the inositol lipid kinase IPMK</article-title><source>Science Signaling</source><volume>5</volume><elocation-id>ra44</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2003111</pub-id><pub-id pub-id-type="pmid">22715467</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>NE</given-names></name><name><surname>Kelly</surname><given-names>KA</given-names></name><name><surname>Hawkins</surname><given-names>R</given-names></name><name><surname>Bramah-Lawani</surname><given-names>M</given-names></name><name><surname>Amelio</surname><given-names>AL</given-names></name><name><surname>Nwachukwu</surname><given-names>JC</given-names></name><name><surname>Nettles</surname><given-names>KW</given-names></name><name><surname>Conkright</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Creb coactivators direct anabolic responses and enhance performance of skeletal muscle</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>1027</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1002/embj.201386145</pub-id><pub-id pub-id-type="pmid">24674967</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catoire</surname><given-names>M</given-names></name><name><surname>Mensink</surname><given-names>M</given-names></name><name><surname>Boekschoten</surname><given-names>MV</given-names></name><name><surname>Hangelbroek</surname><given-names>R</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Schrauwen</surname><given-names>P</given-names></name><name><surname>Kersten</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle</article-title><source>PLoS One</source><volume>7</volume><elocation-id>e51066</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0051066</pub-id><pub-id pub-id-type="pmid">23226462</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>CC</given-names></name><name><surname>Kurrasch</surname><given-names>DM</given-names></name><name><surname>Liang</surname><given-names>JK</given-names></name><name><surname>Ingraham</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetic labeling of steroidogenic factor-1 (SF-1) neurons in mice reveals ventromedial nucleus of the hypothalamus (VMH) circuitry beginning at neurogenesis and development of a separate non-SF-1 neuronal cluster in the ventrolateral VMH</article-title><source>Journal of Comparative Neurology</source><volume>521</volume><fpage>1268</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.1002/cne.23226</pub-id><pub-id pub-id-type="pmid">22987798</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiarreotto-Ropelle</surname><given-names>EC</given-names></name><name><surname>Pauli</surname><given-names>LSS</given-names></name><name><surname>Katashima</surname><given-names>CK</given-names></name><name><surname>Pimentel</surname><given-names>GD</given-names></name><name><surname>Picardi</surname><given-names>PK</given-names></name><name><surname>Silva</surname><given-names>VRR</given-names></name><name><surname>de Souza</surname><given-names>CT</given-names></name><name><surname>Prada</surname><given-names>PO</given-names></name><name><surname>Cintra</surname><given-names>DE</given-names></name><name><surname>Carvalheira</surname><given-names>JBC</given-names></name><name><surname>Ropelle</surname><given-names>ER</given-names></name><name><surname>Pauli</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Acute exercise suppresses hypothalamic PTP1B protein level and improves insulin and leptin signaling in obese rats</article-title><source>AJP: Endocrinology and Metabolism</source><volume>305</volume><fpage>E649</fpage><lpage>E659</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00272.2013</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Fujikawa</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Reuter</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Revisiting the ventral medial nucleus of the hypothalamus: The roles of SF-1 neurons in energy homeostasis</article-title><source>Frontiers in Neuroscience</source><volume>7</volume><elocation-id>71</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2013.00071</pub-id><pub-id pub-id-type="pmid">23675313</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>JC</given-names></name><name><surname>Ferreira</surname><given-names>DM</given-names></name><name><surname>Ruas</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Intercellular: local and systemic actions of skeletal muscle PGC-1s</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>26</volume><fpage>305</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2015.03.010</pub-id><pub-id pub-id-type="pmid">25934582</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotman</surname><given-names>CW</given-names></name><name><surname>Berchtold</surname><given-names>NC</given-names></name><name><surname>Christie</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Exercise builds brain health: key roles of growth factor cascades and inflammation</article-title><source>Trends in Neurosciences</source><volume>30</volume><fpage>464</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2007.06.011</pub-id><pub-id pub-id-type="pmid">17765329</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diffee</surname><given-names>GM</given-names></name><name><surname>Kalfas</surname><given-names>K</given-names></name><name><surname>Al-Majid</surname><given-names>S</given-names></name><name><surname>McCarthy</surname><given-names>DO</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Altered expression of skeletal muscle myosin isoforms in cancer cachexia</article-title><source>AJP: Cell Physiology</source><volume>283</volume><fpage>C1376</fpage><lpage>C1382</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00154.2002</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="report"><person-group person-group-type="author"><name><surname>Dobbs</surname><given-names>R</given-names></name><name><surname>Sawers</surname><given-names>C</given-names></name><name><surname>Thompson</surname><given-names>F</given-names></name><name><surname>Manyika</surname><given-names>J</given-names></name><name><surname>Woetzel</surname><given-names>J</given-names></name><name><surname>Child</surname><given-names>P</given-names></name><name><surname>McKenna</surname><given-names>S</given-names></name><name><surname>Spatharou</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><source>How the World Could Better Fight Obesity</source><publisher-name>The McKinsey Global Institute</publisher-name></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubé</surname><given-names>JJ</given-names></name><name><surname>Sitnick</surname><given-names>MT</given-names></name><name><surname>Schoiswohl</surname><given-names>G</given-names></name><name><surname>Wills</surname><given-names>RC</given-names></name><name><surname>Basantani</surname><given-names>MK</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Pulinilkunnil</surname><given-names>T</given-names></name><name><surname>Kershaw</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adipose triglyceride lipase deletion from adipocytes, but not skeletal myocytes, impairs acute exercise performance in mice</article-title><source>American Journal of Physiology - Endocrinology and Metabolism</source><volume>308</volume><fpage>E879</fpage><lpage>E890</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00530.2014</pub-id><pub-id pub-id-type="pmid">25783895</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>B</given-names></name><name><surname>O'Connor</surname><given-names>PL</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name><name><surname>O'Gorman</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Time course analysis reveals gene-specific transcript and protein kinetics of adaptation to short-term aerobic exercise training in human skeletal muscle</article-title><source>PLoS One</source><volume>8</volume><elocation-id>e74098</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0074098</pub-id><pub-id pub-id-type="pmid">24069271</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>B</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Exercise metabolism and the molecular regulation of skeletal muscle adaptation</article-title><source>Cell Metabolism</source><volume>17</volume><fpage>162</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.12.012</pub-id><pub-id pub-id-type="pmid">23395166</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Marcos</surname><given-names>PJ</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis</article-title><source>American Journal of Clinical Nutrition</source><volume>93</volume><fpage>884S</fpage><lpage>890S</lpage><pub-id pub-id-type="doi">10.3945/ajcn.110.001917</pub-id><pub-id pub-id-type="pmid">21289221</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujikawa</surname><given-names>T</given-names></name><name><surname>Chuang</surname><given-names>J-C</given-names></name><name><surname>Sakata</surname><given-names>I</given-names></name><name><surname>Ramadori</surname><given-names>G</given-names></name><name><surname>Coppari</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice</article-title><source>PNAS</source><volume>107</volume><fpage>17391</fpage><lpage>17396</lpage><pub-id pub-id-type="doi">10.1073/pnas.1008025107</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautron</surname><given-names>L</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name><name><surname>Williams</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neural control of energy balance: translating circuits to therapies</article-title><source>Cell</source><volume>161</volume><fpage>133</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.02.023</pub-id><pub-id pub-id-type="pmid">25815991</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handschin</surname><given-names>C</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The role of exercise and PGC1alpha in inflammation and chronic disease</article-title><source>Nature</source><volume>454</volume><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1038/nature07206</pub-id><pub-id pub-id-type="pmid">18650917</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>MS</given-names></name><name><surname>Minokoshi</surname><given-names>Y</given-names></name><name><surname>Hamai</surname><given-names>M</given-names></name><name><surname>Iwai</surname><given-names>M</given-names></name><name><surname>Horiuchi</surname><given-names>M</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats</article-title><source>Diabetes</source><volume>48</volume><fpage>1706</fpage><lpage>1712</lpage><pub-id pub-id-type="doi">10.2337/diabetes.48.9.1706</pub-id><pub-id pub-id-type="pmid">10480598</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname><given-names>JA</given-names></name><name><surname>Hargreaves</surname><given-names>M</given-names></name><name><surname>Joyner</surname><given-names>MJ</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Integrative biology of exercise</article-title><source>Cell</source><volume>159</volume><fpage>738</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.029</pub-id><pub-id pub-id-type="pmid">25417152</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>C</given-names></name><name><surname>Bassik</surname><given-names>MC</given-names></name><name><surname>Moresi</surname><given-names>V</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>An</surname><given-names>Z</given-names></name><name><surname>Loh</surname><given-names>J</given-names></name><name><surname>Fisher</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Korsmeyer</surname><given-names>S</given-names></name><name><surname>Packer</surname><given-names>M</given-names></name><name><surname>May</surname><given-names>HI</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name><name><surname>Gilpin</surname><given-names>C</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name><name><surname>Scherer</surname><given-names>PE</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis</article-title><source>Nature</source><volume>481</volume><fpage>511</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1038/nature10758</pub-id><pub-id pub-id-type="pmid">22258505</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horowitz</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Fatty acid mobilization from adipose tissue during exercise</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>14</volume><fpage>386</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/S1043-2760(03)00143-7</pub-id><pub-id pub-id-type="pmid">14516937</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Donato</surname><given-names>J</given-names></name><name><surname>Berglund</surname><given-names>ED</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Kohno</surname><given-names>D</given-names></name><name><surname>Elias</surname><given-names>CF</given-names></name><name><surname>Depinho</surname><given-names>RA</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>FOXO1 in the ventromedial hypothalamus regulates energy balance</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>2578</fpage><lpage>2589</lpage><pub-id pub-id-type="doi">10.1172/JCI62848</pub-id><pub-id pub-id-type="pmid">22653058</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Jo</surname><given-names>YH</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Stallings</surname><given-names>NR</given-names></name><name><surname>Chua</surname><given-names>SC</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleus</article-title><source>Molecular Endocrinology</source><volume>22</volume><fpage>1950</fpage><lpage>1961</lpage><pub-id pub-id-type="doi">10.1210/me.2008-0127</pub-id><pub-id pub-id-type="pmid">18511494</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Sohn</surname><given-names>JW</given-names></name><name><surname>Kohno</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Williams</surname><given-names>K</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>SF-1 in the ventral medial hypothalamic nucleus: a key regulator of homeostasis</article-title><source>Molecular and Cellular Endocrinology</source><volume>336</volume><fpage>219</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2010.11.019</pub-id><pub-id pub-id-type="pmid">21111025</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Donato</surname><given-names>J</given-names></name><name><surname>Kohno</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Elias</surname><given-names>CF</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name><name><surname>Jr.</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Elias</surname><given-names>Y</given-names></name><name><surname>Parker</surname><given-names>C</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus</article-title><source>PNAS</source><volume>108</volume><fpage>10673</fpage><lpage>10678</lpage><pub-id pub-id-type="doi">10.1073/pnas.1102364108</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Parker</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Central nervous system-specific knockout of steroidogenic factor 1</article-title><source>Molecular and Cellular Endocrinology</source><volume>300</volume><fpage>132</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2008.09.026</pub-id><pub-id pub-id-type="pmid">18951950</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight</article-title><source>Physiology &amp; Behavior</source><volume>87</volume><fpage>221</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2005.10.007</pub-id><pub-id pub-id-type="pmid">16412483</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Fowler</surname><given-names>SE</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><name><surname>Nathan</surname><given-names>DM</given-names></name><collab>Diabetes Prevention Program Research Group</collab></person-group><year iso-8601-date="2002">2002</year><article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title><source>The New England Journal of Medicine</source><volume>346</volume><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa012512</pub-id><pub-id pub-id-type="pmid">11832527</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koopman</surname><given-names>R</given-names></name><name><surname>Gehrig</surname><given-names>SM</given-names></name><name><surname>Léger</surname><given-names>B</given-names></name><name><surname>Trieu</surname><given-names>J</given-names></name><name><surname>Walrand</surname><given-names>S</given-names></name><name><surname>Murphy</surname><given-names>KT</given-names></name><name><surname>Lynch</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice</article-title><source>The Journal of Physiology</source><volume>588</volume><fpage>4811</fpage><lpage>4823</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2010.196725</pub-id><pub-id pub-id-type="pmid">20937713</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusminski</surname><given-names>CM</given-names></name><name><surname>Holland</surname><given-names>WL</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Spurgin</surname><given-names>SB</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Askew</surname><given-names>GR</given-names></name><name><surname>Simcox</surname><given-names>JA</given-names></name><name><surname>McClain</surname><given-names>DA</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Scherer</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity</article-title><source>Nature Medicine</source><volume>18</volume><fpage>1539</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1038/nm.2899</pub-id><pub-id pub-id-type="pmid">22961109</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Conditional viral tracing reveals that steroidogenic factor 1-positive neurons of the dorsomedial subdivision of the ventromedial hypothalamus project to autonomic centers of the hypothalamus and hindbrain</article-title><source>Journal of Comparative Neurology</source><volume>521</volume><fpage>3167</fpage><lpage>3190</lpage><pub-id pub-id-type="doi">10.1002/cne.23338</pub-id><pub-id pub-id-type="pmid">23696474</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Stevens-Lapsley</surname><given-names>JE</given-names></name><name><surname>Jayaraman</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Conover</surname><given-names>C</given-names></name><name><surname>Walter</surname><given-names>GA</given-names></name><name><surname>Bose</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>FJ</given-names></name><name><surname>Borst</surname><given-names>SE</given-names></name><name><surname>Vandenborne</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Impact of treadmill locomotor training on skeletal muscle IGF1 and myogenic regulatory factors in spinal cord injured rats</article-title><source>European Journal of Applied Physiology</source><volume>109</volume><fpage>709</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1007/s00421-010-1392-z</pub-id><pub-id pub-id-type="pmid">20213470</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>GS</given-names></name><name><surname>Ryall</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease</article-title><source>Physiological Reviews</source><volume>88</volume><fpage>729</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1152/physrev.00028.2007</pub-id><pub-id pub-id-type="pmid">18391178</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minokoshi</surname><given-names>Y</given-names></name><name><surname>Haque</surname><given-names>MS</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats</article-title><source>Diabetes</source><volume>48</volume><fpage>287</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.2337/diabetes.48.2.287</pub-id><pub-id pub-id-type="pmid">10334303</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaki</surname><given-names>T</given-names></name><name><surname>Fujikawa</surname><given-names>T</given-names></name><name><surname>Kitaoka</surname><given-names>R</given-names></name><name><surname>Hirano</surname><given-names>N</given-names></name><name><surname>Matsumura</surname><given-names>S</given-names></name><name><surname>Fushiki</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Noradrenergic projections to the ventromedial hypothalamus regulate fat metabolism during endurance exercise</article-title><source>Neuroscience</source><volume>190</volume><fpage>239</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.05.051</pub-id><pub-id pub-id-type="pmid">21640797</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>GJ</given-names></name><name><surname>Meek</surname><given-names>TH</given-names></name><name><surname>Schwartz</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neurobiology of food intake in health and disease</article-title><source>Nature Reviews Neuroscience</source><volume>15</volume><fpage>367</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1038/nrn3745</pub-id><pub-id pub-id-type="pmid">24840801</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>MJ</given-names></name><name><surname>Bosy-Westphal</surname><given-names>A</given-names></name><name><surname>Kutzner</surname><given-names>D</given-names></name><name><surname>Heller</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Metabolically active components of fat-free mass and resting energy expenditure in humans: recent lessons from imaging technologies</article-title><source>Obesity Reviews</source><volume>3</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1046/j.1467-789X.2002.00057.x</pub-id><pub-id pub-id-type="pmid">12120418</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niijima</surname><given-names>A</given-names></name><name><surname>Rohner-Jeanrenaud</surname><given-names>F</given-names></name><name><surname>Jeanrenaud</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Role of ventromedial hypothalamus on sympathetic efferents of brown adipose tissue</article-title><source>The American Journal of Physiology</source><volume>247</volume><fpage>R650</fpage><lpage>R654</lpage><pub-id pub-id-type="pmid">6496714</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>KL</given-names></name><name><surname>Rice</surname><given-names>DA</given-names></name><name><surname>Lala</surname><given-names>DS</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Bakke</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Frigeri</surname><given-names>C</given-names></name><name><surname>Hanley</surname><given-names>NA</given-names></name><name><surname>Stallings</surname><given-names>N</given-names></name><name><surname>Schimmer</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Steroidogenic factor 1: an essential mediator of endocrine development</article-title><source>Recent Progress in Hormone Research</source><volume>57</volume><fpage>19</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1210/rp.57.1.19</pub-id><pub-id pub-id-type="pmid">12017543</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearen</surname><given-names>MA</given-names></name><name><surname>Ryall</surname><given-names>JG</given-names></name><name><surname>Lynch</surname><given-names>GS</given-names></name><name><surname>Muscat</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm</article-title><source>BMC Genomics</source><volume>10</volume><elocation-id>448</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-10-448</pub-id><pub-id pub-id-type="pmid">19772666</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>MN</given-names></name><name><surname>Rothwell</surname><given-names>NJ</given-names></name><name><surname>Stock</surname><given-names>MJ</given-names></name><name><surname>Stone</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus</article-title><source>Nature</source><volume>289</volume><fpage>401</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/289401a0</pub-id><pub-id pub-id-type="pmid">7464907</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramadori</surname><given-names>G</given-names></name><name><surname>Fujikawa</surname><given-names>T</given-names></name><name><surname>Anderson</surname><given-names>J</given-names></name><name><surname>Berglund</surname><given-names>ED</given-names></name><name><surname>Frazao</surname><given-names>R</given-names></name><name><surname>Michán</surname><given-names>S</given-names></name><name><surname>Vianna</surname><given-names>CR</given-names></name><name><surname>Sinclair</surname><given-names>DA</given-names></name><name><surname>Elias</surname><given-names>CF</given-names></name><name><surname>Coppari</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance</article-title><source>Cell Metabolism</source><volume>14</volume><fpage>301</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.06.014</pub-id><pub-id pub-id-type="pmid">21907137</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruas</surname><given-names>JL</given-names></name><name><surname>White</surname><given-names>JP</given-names></name><name><surname>Rao</surname><given-names>RR</given-names></name><name><surname>Kleiner</surname><given-names>S</given-names></name><name><surname>Brannan</surname><given-names>KT</given-names></name><name><surname>Harrison</surname><given-names>BC</given-names></name><name><surname>Greene</surname><given-names>NP</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Estall</surname><given-names>JL</given-names></name><name><surname>Irving</surname><given-names>BA</given-names></name><name><surname>Lanza</surname><given-names>IR</given-names></name><name><surname>Rasbach</surname><given-names>KA</given-names></name><name><surname>Okutsu</surname><given-names>M</given-names></name><name><surname>Nair</surname><given-names>KS</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Leinwand</surname><given-names>LA</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy</article-title><source>Cell</source><volume>151</volume><fpage>1319</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.10.050</pub-id><pub-id pub-id-type="pmid">23217713</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruffin</surname><given-names>M</given-names></name><name><surname>Nicolaidis</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Electrical stimulation of the ventromedial hypothalamus enhances both fat utilization and metabolic rate that precede and parallel the inhibition of feeding behavior</article-title><source>Brain Research</source><volume>846</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(99)01922-8</pub-id><pub-id pub-id-type="pmid">10536210</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>T</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="1987">1987a</year><article-title>The effect of intrahypothalamic injections of glucose on sympathetic efferent firing rate</article-title><source>Brain Research Bulletin</source><volume>18</volume><fpage>591</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1016/0361-9230(87)90128-6</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>T</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="1987">1987b</year><article-title>Intrahypothalamic injection of insulin decreases firing rate of sympathetic nerves</article-title><source>PNAS</source><volume>84</volume><fpage>2012</fpage><lpage>2014</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.7.2012</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>T</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Eddlestone</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Sympathetic activity following paraventricular or ventromedial hypothalamic lesions in rats</article-title><source>Brain Research Bulletin</source><volume>20</volume><fpage>461</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/0361-9230(88)90135-9</pub-id><pub-id pub-id-type="pmid">3293706</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandri</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Handschin</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Arany</surname><given-names>ZP</given-names></name><name><surname>Lecker</surname><given-names>SH</given-names></name><name><surname>Goldberg</surname><given-names>AL</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription</article-title><source>PNAS</source><volume>103</volume><fpage>16260</fpage><lpage>16265</lpage><pub-id pub-id-type="doi">10.1073/pnas.0607795103</pub-id><pub-id pub-id-type="pmid">17053067</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheurink</surname><given-names>AJ</given-names></name><name><surname>Steffens</surname><given-names>AB</given-names></name><name><surname>Benthem</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Central and peripheral adrenoceptors affect glucose, free fatty acids, and insulin in exercising rats</article-title><source>The American Journal of Physiology</source><volume>255</volume><fpage>R547</fpage><lpage>R556</lpage><pub-id pub-id-type="pmid">2845819</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiuchi</surname><given-names>T</given-names></name><name><surname>Haque</surname><given-names>MS</given-names></name><name><surname>Okamoto</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Kageyama</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Toda</surname><given-names>C</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Bachman</surname><given-names>ES</given-names></name><name><surname>Kim</surname><given-names>YB</given-names></name><name><surname>Sakurai</surname><given-names>T</given-names></name><name><surname>Yanagisawa</surname><given-names>M</given-names></name><name><surname>Shioda</surname><given-names>S</given-names></name><name><surname>Imoto</surname><given-names>K</given-names></name><name><surname>Minokoshi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system</article-title><source>Cell Metabolism</source><volume>10</volume><fpage>466</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2009.09.013</pub-id><pub-id pub-id-type="pmid">19945404</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Hypothalamic regulation of lipid metabolism in the rat: effect of hypothalamic stimulation on lipolysis</article-title><source>Journal of the Autonomic Nervous System</source><volume>4</volume><fpage>195</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/0165-1838(81)90044-8</pub-id><pub-id pub-id-type="pmid">7299038</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Shimazu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Hypothalamic regulation of lipid metabolism in the rat: effect of hypothalamic stimulation on lipogenesis</article-title><source>Journal of the Autonomic Nervous System</source><volume>6</volume><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/0165-1838(82)90053-4</pub-id><pub-id pub-id-type="pmid">6757306</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takimoto</surname><given-names>M</given-names></name><name><surname>Hamada</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins</article-title><source>Journal of Applied Physiology</source><volume>116</volume><fpage>1238</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01288.2013</pub-id><pub-id pub-id-type="pmid">24610532</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>EB</given-names></name><name><surname>An</surname><given-names>D</given-names></name><name><surname>Kramer</surname><given-names>HF</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Fujii</surname><given-names>NL</given-names></name><name><surname>Roeckl</surname><given-names>KS</given-names></name><name><surname>Bowles</surname><given-names>N</given-names></name><name><surname>Hirshman</surname><given-names>MF</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Feener</surname><given-names>EP</given-names></name><name><surname>Goodyear</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>9787</fpage><lpage>9796</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708839200</pub-id><pub-id pub-id-type="pmid">18276596</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Q</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>McCrimmon</surname><given-names>RJ</given-names></name><name><surname>Dhillon</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>B</given-names></name><name><surname>Kramer</surname><given-names>MD</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Christiansen</surname><given-names>LM</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Choi</surname><given-names>CS</given-names></name><name><surname>Zigman</surname><given-names>JM</given-names></name><name><surname>Shulman</surname><given-names>GI</given-names></name><name><surname>Sherwin</surname><given-names>RS</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia</article-title><source>Cell Metabolism</source><volume>5</volume><fpage>383</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.04.001</pub-id><pub-id pub-id-type="pmid">17488640</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>PV</given-names></name><name><surname>Akana</surname><given-names>SF</given-names></name><name><surname>Malkovska</surname><given-names>I</given-names></name><name><surname>Dallman</surname><given-names>MF</given-names></name><name><surname>Parada</surname><given-names>LF</given-names></name><name><surname>Ingraham</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage</article-title><source>The Journal of Comparative Neurology</source><volume>498</volume><fpage>637</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1002/cne.21070</pub-id><pub-id pub-id-type="pmid">16917842</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschöp</surname><given-names>MH</given-names></name><name><surname>Speakman</surname><given-names>JR</given-names></name><name><surname>Arch</surname><given-names>JRS</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name><name><surname>Brüning</surname><given-names>JC</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Farese</surname><given-names>RV</given-names></name><name><surname>Galgani</surname><given-names>JE</given-names></name><name><surname>Hambly</surname><given-names>C</given-names></name><name><surname>Herman</surname><given-names>MA</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name><name><surname>Kozma</surname><given-names>SC</given-names></name><name><surname>Maratos-Flier</surname><given-names>E</given-names></name><name><surname>Müller</surname><given-names>TD</given-names></name><name><surname>Münzberg</surname><given-names>H</given-names></name><name><surname>Pfluger</surname><given-names>PT</given-names></name><name><surname>Plum</surname><given-names>L</given-names></name><name><surname>Reitman</surname><given-names>ML</given-names></name><name><surname>Rahmouni</surname><given-names>K</given-names></name><name><surname>Shulman</surname><given-names>GI</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A guide to analysis of mouse energy metabolism</article-title><source>Nature Methods</source><volume>9</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1806</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Heide</surname><given-names>LP</given-names></name><name><surname>Hoekman</surname><given-names>MF</given-names></name><name><surname>Smidt</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation</article-title><source>Biochemical Journal</source><volume>380</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1042/bj20040167</pub-id><pub-id pub-id-type="pmid">15005655</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viguerie</surname><given-names>N</given-names></name><name><surname>Clement</surname><given-names>K</given-names></name><name><surname>Barbe</surname><given-names>P</given-names></name><name><surname>Courtine</surname><given-names>M</given-names></name><name><surname>Benis</surname><given-names>A</given-names></name><name><surname>Larrouy</surname><given-names>D</given-names></name><name><surname>Hanczar</surname><given-names>B</given-names></name><name><surname>Pelloux</surname><given-names>V</given-names></name><name><surname>Poitou</surname><given-names>C</given-names></name><name><surname>Khalfallah</surname><given-names>Y</given-names></name><name><surname>Barsh</surname><given-names>GS</given-names></name><name><surname>Thalamas</surname><given-names>C</given-names></name><name><surname>Zucker</surname><given-names>JD</given-names></name><name><surname>Langin</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>In vivo epinephrine-mediated regulation of gene expression in human skeletal muscle</article-title><source>The Journal of Clinical Endocrinology &amp; Metabolism</source><volume>89</volume><fpage>2000</fpage><lpage>2014</lpage><pub-id pub-id-type="doi">10.1210/jc.2003-031733</pub-id><pub-id pub-id-type="pmid">15126512</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>IZ</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Collateral pathways from the ventromedial hypothalamus mediate defensive behaviors</article-title><source>Neuron</source><volume>85</volume><fpage>1344</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.025</pub-id><pub-id pub-id-type="pmid">25754823</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Hill</surname><given-names>JW</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Gautron</surname><given-names>L</given-names></name><name><surname>Sohn</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Choi</surname><given-names>MJ</given-names></name><name><surname>Lauzon</surname><given-names>DA</given-names></name><name><surname>Dhillon</surname><given-names>H</given-names></name><name><surname>Lowell</surname><given-names>BB</given-names></name><name><surname>Zigman</surname><given-names>JM</given-names></name><name><surname>Zhao</surname><given-names>JJ</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PI3K signaling in the ventromedial hypothalamic nucleus is required for normal energy homeostasis</article-title><source>Cell Metabolism</source><volume>12</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2010.05.002</pub-id><pub-id pub-id-type="pmid">20620998</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Kishi</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Choi</surname><given-names>BJ</given-names></name><name><surname>Fang</surname><given-names>H</given-names></name><name><surname>Hollenberg</surname><given-names>AN</given-names></name><name><surname>Drucker</surname><given-names>DJ</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites</article-title><source>Journal of Neuroscience</source><volume>23</volume><fpage>2939</fpage><lpage>2946</lpage><pub-id pub-id-type="pmid">12684481</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Marcus</surname><given-names>JN</given-names></name><name><surname>Williams</surname><given-names>TD</given-names></name><name><surname>Overton</surname><given-names>JM</given-names></name><name><surname>Lopez</surname><given-names>ME</given-names></name><name><surname>Hollenberg</surname><given-names>AN</given-names></name><name><surname>Baggio</surname><given-names>L</given-names></name><name><surname>Saper</surname><given-names>CB</given-names></name><name><surname>Drucker</surname><given-names>DJ</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons</article-title><source>Journal of Clinical Investigation</source><volume>110</volume><fpage>43</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1172/JCI0215595</pub-id><pub-id pub-id-type="pmid">12093887</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Endurance exercise is a leptin signaling mimetic in hypothalamus of Wistar rats</article-title><source>Lipids in Health and Disease</source><volume>10</volume><fpage>225</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-225</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.18206.017</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Palmiter</surname><given-names>Richard D</given-names></name><role>Reviewing editor</role><aff id="aff11"><institution>Howard Hughes Medical Institute, University of Washington</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;SF-1 Expression in the Hypothalalmus is Required for Beneficial Metabolic Effects of Exercise&quot; for consideration by <italic>eLife</italic>. Your article has been favorably evaluated by a Senior Editor and three reviewers, one of whom, Richard D Palmiter (Reviewer #1), is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal their identity: Matthias Tschöp (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The authors of this paper examine the role of transcription factor SF-1 in the VMH on the beneficial effects of exercise. They find that many of the beneficial effects are blunted in mice with genetic disruption of the Nr5a1 gene (that encodes Sf-1) in CamKII-expressing neurons. The authors find that the increases in mass of various muscles after chronic exercise is blunted in the mice lacking SF-1 and suggest that defects in sympathetic nervous system (SNS) outflow to muscle is likely responsible. Although the authors do not directly examine SNS activity in this study, there is a large body of data implicating the VMH and SF-1-expressing neurons in particular in control of SNS. The design of the experiments is sound, but there are some aspects of the study that are inconsistent and other aspects that require some explanation.</p><p>Essential revisions:</p><p>1) In <xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, the authors show that 5 weeks of exercise largely prevents weight gain in control mice but has a greatly diminished effect on weight gain in the mice lacking SF-1 in the VMH (hereafter KO mice) and this effect is largely due to decreased fat accumulation (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). However, in <xref ref-type="fig" rid="fig3">Figure 3D and E</xref>, the authors repeat this experiment with 8 weeks of exercise and find that the change in body weight is not significantly different between groups and there is no significant effect of exercise on prevention of fat accumulation when comparing the two genotypes (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). An experimental explanation for this lack of repeatability is essential. One would naturally assume that a longer period of exercise would have even a greater effect rather than a diminished effect of weight gain and fat accumulation.</p><p>2) The second concern is that athletes generally exercise to gain lean mass at the expense of fat mass. Yet in the data presented in <xref ref-type="fig" rid="fig2">Figure 2D</xref> there is a decrease in lean mass with exercise in both groups of mice and in <xref ref-type="fig" rid="fig3">Figure 3G</xref> there is a decrease in the KO mice. While the decrease in lean mass in KO mice might be expected, the decrease in control mice is not. Furthermore, when the authors measure the mass of specific muscles (<xref ref-type="fig" rid="fig4">Figure 4B-D</xref>) there is an increase in mass in the control mice (but not in KO mice). If muscle mass is increasing with exercise, what lean mass is decreasing in these experiments when whole body lean mass is measured?</p><p>3) The data showing that Ppargc1a mRNAs levels are not increased as much in KO muscle as in WT muscle is an interesting observation, but begs for more analysis. It would be useful to have some data linking the change in mRNA with changes in SNS tone. The authors speculate that the change in mRNA might be associated with decreased synthesis or increased degradation of muscle proteins. Analysis of mRNAs associated with muscle synthesis or degradation would add nicely to this study.</p><p>4) As mentioned in this paper, attenuation of exercise-induced reduction of fat mass appears to be mediated by the impairment of the sympathetic nervous system activation. However, this paper does not show any direct evidence. Reviewer asks the measurement of plasma concentration of catecholamines after exercise. Measurement of plasma levels of glucagon and insulin would also be useful.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.18206.018</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>[…]</italic></p><p><italic>Essential revisions:</italic> </p><p><italic>1) In <xref ref-type="fig" rid="fig2">Figure 2A and B</xref>, the authors show that 5 weeks of exercise largely prevents weight gain in control mice but has a greatly diminished effect on weight gain in the mice lacking SF-1 in the VMH (hereafter KO mice) and this effect is largely due to decreased fat accumulation (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). However, in <xref ref-type="fig" rid="fig3">Figure 3D and E</xref>, the authors repeat this experiment with 8 weeks of exercise and find that the change in body weight is not significantly different between groups and there is no significant effect of exercise on prevention of fat accumulation when comparing the two genotypes (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). An experimental explanation for this lack of repeatability is essential. One would naturally assume that a longer period of exercise would have even a greater effect rather than a diminished effect of weight gain and fat accumulation.</italic> </p><p>We apologize for the confusion. In <xref ref-type="fig" rid="fig2">Figure 2</xref>, we paired prolonged exercise with diet-induced obesity (high-fat diet,60% of calories from fat) to recapitulate the effects of exercise in obese humans. In the remaining figures (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig4">4</xref> and figure supplements), mice were fed normal chow-diet(please see Materials and methods for detailed diet information). We observed that chow-fed KO mice had larger fat depots after 4 weeks of exercise training as compared to control mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). While not statistically significant, there was a trend towards decreased fat mass in chow fed trained-KO mice (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). We have clarified the experimental conditions in the subsection “Deletion of SF-1 in the VMH blunts metabolic adaptations of skeletal muscle in response to exercise”, first paragraph.</p><p><italic>2) The second concern is that athletes generally exercise to gain lean mass at the expense of fat mass. Yet in the data presented in <xref ref-type="fig" rid="fig2">Figure 2D</xref> there is a decrease in lean mass with exercise in both groups of mice and in <xref ref-type="fig" rid="fig3">Figure 3G</xref> there is a decrease in the KO mice. While the decrease in lean mass in KO mice might be expected, the decrease in control mice is not.</italic> </p><p>This is an excellent point. Obese individuals require increased muscle and bone mass to support their excessive fat depot, hence they have both increased lean and fat mass. However, the proportion of lean mass is lower compared to the non-obese subjects.</p><p>As the reviewers pointed out, exercise training is thought to prevent the accumulation of fat while increasing or maintaining lean mass. This is certainly the case in human studies. However, as outlined below rodent studies are difficult to interpret in this regard. The type of exercise adaptation is dependent on a number of factors such as mode, duration, intensity, and frequency of exercise. Treadmill training in mice is a weight bearing exercise. Therefore, obese-exercised mice (<xref ref-type="fig" rid="fig2">Figure 2</xref>) have ~25% lower body weight compared to obese-sedentary mice, and thus require less muscle mass to support normal cage activity and exercise. Furthermore, the exercised mice have improved body composition (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><p>Chow-fed mice do not have excessive amounts of fat (<xref ref-type="fig" rid="fig3">Figure 3D</xref>; ~10% greater body mass control sedentary versus control trained). Therefore, treadmill adaptation results in the maintenance of absolute lean mass and reduction of fat mass, which significantly improves body composition (<xref ref-type="fig" rid="fig3">Figure 3F-H</xref>). Overall, our data suggest that SF-1 in the VMH is required for exercise training induced improvements in body composition.</p><p><italic>Furthermore, when the authors measure the mass of specific muscles (<xref ref-type="fig" rid="fig4">Figure 4B-D</xref>) there is an increase in mass in the control mice (but not in KO mice). If muscle mass is increasing with exercise, what lean mass is decreasing in these experiments when whole body lean mass is measured?</italic> </p><p>Based on previous studies (Hafstad et al., 2011; Kitaoka et al., 2010; Soya et al., 2007), we estimate that the intensity of our exercise training protocol is around 65-70% VO<sub>2</sub> max. This degree of intensity on a treadmill apparatus is not expected to result in significant gain of lean mass. Indeed, we found that this training protocol improved body composition in chow-fed mice by maintaining lean mass while reducing fat mass (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B, C</xref>). We chose to express skeletal muscle weight relative to total body weight (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) to account for differences in body weight, as increased body mass can increase lean mass. To clarify these data, we have added the body weight data after 4 weeks of exercise training to <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>.</p><p><italic>3) The data showing that Ppargc1a mRNAs levels are not increased as much in KO muscle as in WT muscle is an interesting observation, but begs for more analysis. It would be useful to have some data linking the change in mRNA with changes in SNS tone. The authors speculate that the change in mRNA might be associated with decreased synthesis or increased degradation of muscle proteins. Analysis of mRNAs associated with muscle synthesis or degradation would add nicely to this study.</italic> </p><p>Thank you for these important suggestions. Accordingly, we have performed additional studies in this regard. <italic>Nr4a2, Crem, Foxo1</italic>, and <italic>Smad3</italic>, are regulated by epinephrine, β2AdR-agonist administration, or exercise (Catoire et al., 2012; Egan et al., 2013; Pearen et al., 2009; Viguerie et al., 2004). mRNA levels of these genes were measured after a single exercise session as shown in <xref ref-type="fig" rid="fig4">Figures 4F-J</xref>. Although no statistical differences in gene expression were found between genotypes, exercised-KO mice did have higher mRNA levels of <italic>Crem</italic> compared to exercised-control mice. <italic>Crem</italic> is reported to reciprocally regulate CREB target genes in the skeletal muscle (Viguerie et al., 2004) (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5A-D</xref>). This result, along with our data showing that phosphorylation of CREB in skeletal muscle of KO mice is blunted in response to exercise (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), suggests that deletion of SF-1 in the VMH affects the CREB signaling pathway.</p><p>We also measured mRNA levels associated with muscle synthesis (Myog, Myod1) and degradation (Fbxo32 and Ctsl) after a single bout of middle-intensity exercise (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5E-H</xref>). Compared to sedentary-KO mice, exercised-KO mice had significantly higher levels of <italic>Myog</italic> (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5E</xref>), and higher, but not significant, levels of <italic>Fbxo32</italic> (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5G</xref>). Gene expression remained unchanged in control mice. We speculate that deletion of SF-1 in the hypothalamus may disrupt protein turnover, ultimately causing a maladaptation of skeletal muscle in response to exercise as seen in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p><p><italic>4) As mentioned in this paper, attenuation of exercise-induced reduction of fat mass appears to be mediated by the impairment of the sympathetic nervous system activation. However, this paper does not show any direct evidence. Reviewer asks the measurement of plasma concentration of catecholamines after exercise. Measurement of plasma levels of glucagon and insulin would also be useful.</italic> </p><p>The reviewer raises an excellent point, and we have now addressed this concern. We found no statistical differences in circulating glucagon and insulin immediately after a single bout of exercise (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C and D</xref>). In line with other studies (Galbo et al., 1975; Rowell et al., 1987; Soya et al., 2007), our exercise paradigm (15m/min for 60 minutes) did not dramatically increase circulating epinephrine and norepinephrine levels (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A and B</xref>). However, epinephrine levels of KO mice were significantly lower after exercise compared to control mice. As the reviewers know, obtaining unstressed levels of plasma catecholamines in mice is inherently difficult. Thus, as an additional measure of sympathetic nervous system activity, we assessed the transcriptional activity of tyrosine hydroxylase (TH) in the adrenal medulla of exercised mice. In particular, we quantified pre-mRNA (intronic) TH mRNA levels in the adrenal grand as a surrogate marker of sympathetic nervous activity (Yamamoto et al., 2003; Yamamoto et al., 2002). Interestingly, exercise increased pre-mRNA levels of TH in the adrenal gland of control mice, but not in KO mice (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2E</xref>). Collectively, we think our data suggest support the model that deletion of SF-1 in the VMH hampers the ability of VMH-adrenal gland-axis of the sympathetic nervous system to respond to exercise.</p></body></sub-article></article>